Carbazole

Carbazole

SCHEMBL9960082

OB(O)O.c1ccc2c(c1)[nH]c1ccccc12

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.78
GPR3 P46089 2/20 0.78
HSD17B10 Q99714 2/20 0.78
AHR P35869 1/20 0.64
KDM4E B2RXH2 3/20 0.56
LMNA P02545 2/20 0.56
HPGD P15428 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
GLA P06280 1/20 0.56
GAA P10253 1/20 0.56
HTT P42858 1/20 0.56
ATM Q13315 1/20 0.56
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
TNKS O95271 1/20 0.52
CYP1A2 P05177 1/20 0.52
PARP1 P09874 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
PARP15 Q460N3 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbazole SCHEMBL29779348 1.00 ALDH1A1 (0.78) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL28065133 1.00 ALDH1A1 (0.78) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL30307050 1.00 ALDH1A1 (0.78) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL28389121 1.00 ALDH1A1 (0.78) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL29355407 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL29627417 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL30209164 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL30761795 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL370524 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E
Carbazole SCHEMBL7650 0.88 ALDH1A1 (1.00) ALDH1A1GPR3HSD17B10AHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112300201-B Synthesis and preparation method of trimeric indenyl coumarin-corrole-porphyrin quaternary system star-shaped compound 南京林业大学 2021-11-23 CN claimed
CN-112300201-A Synthesis and preparation method of trimeric indenyl coumarin-corrole-porphyrin quaternary system star-shaped compound 南京林业大学 2021-02-02 CN claimed
CN-106831815-B A kind of A-D-A type small organic molecule receptor of seven yuan of condensed ring of carbazoles containing thieno and preparation method thereof 湘潭大学 2019-06-28 CN claimed
CN-109897055-A A kind of organic compound and its preparation method and application based on union II carbazole and imidodicarbonic diamide 山东师范大学 2019-06-18 CN claimed
CN-109253990-A Nano fluorescent probe for targeting pancreatic cancer circulating tumor cells 上海交通大学医学院附属瑞金医院 2019-01-22 CN claimed
CN-107955138-A A kind of the water soluble fluorescence polymer based on Bodipy- carbazole structures, its synthetic method and application 黄河科技学院 2018-04-24 CN claimed
CN-106831815-A A kind of A-D-A type organic molecule acceptors of seven yuan of condensed ring of carbazoles containing thieno and preparation method thereof 湘潭大学 2017-06-13 CN claimed
CN-120923403-A Novel electroluminescent material and organic electronic device 安庆飞凯新材料有限公司 2025-11-11 CN disclosed
CN-108440573-B Compound, preparation method and organic light-emitting display device 武汉天马微电子有限公司 2022-05-20 CN disclosed
CN-113801154-A Synthesis method of 9H-carbazole-2-boronic acid pinacol ester with C2-position of carbazole directly boronated by C-H 中钢集团南京新材料研究院有限公司 2021-12-17 CN disclosed
CN-109253990-B Nano fluorescent probe for targeting pancreatic cancer circulating tumor cells 上海交通大学医学院附属瑞金医院 2021-10-15 CN disclosed
CN-113429402-A Thermal activation delayed fluorescent material based on dibenzothiophene sulfone 西安交通大学 2021-09-24 CN disclosed
CN-110078738-A A kind of A-D-A type nanometer unfilled corner grid and its preparation method and application with thermal activation delayed fluorescence property 南京邮电大学 2019-08-02 CN disclosed
CN-106188505-A A kind of modified polycarbazole and preparation method thereof 广东工业大学 2016-12-07 CN disclosed
US-20160280772-A1 Polypeptides, Cells, and Methods for Biofilm Therapy and Detection REGENTS OF THE UNIVERSITY OF MINNESOTA 2016-09-29 US disclosed
US-20160074466-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS TARIX PHARMACEUTICALS LTD. 2016-03-17 US disclosed
US-20150057216-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS UNIVERSITY OF SOUTHERN CALIFORNIA 2015-02-26 US disclosed
EP-2790716-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS Tarix Pharmaceuticals Ltd. (US) 2014-10-22 EP disclosed
WO-2013090833-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS TARIX PHARMACEUTICALS LTD. (US) 2013-06-20 WO disclosed
WO-2012088316-A1 2-ALKYL-5-PHENYL OXADIAZOLE-CARBAZOLE HOSTS FOR GUEST EMITTERS GEORGIA TECH RESEARCH CORPORATION (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160074466-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS AGT, REN, AGTR1 ALDH1A1 1184/4885GPR3 756/4885HSD17B10 3389/4885
US-20150057216-A1 ANGIOTENSINS FOR TREATMENT OF FIBROSIS AGT, REN, AGTR1 ALDH1A1 1184/4885GPR3 756/4885HSD17B10 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.